Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.
CONCLUSIONS: About half of commercially-insured T2DM patients discontinued SU within one year after insulin initiation, and SU discontinuation was not strongly associated with a range of patient and provider characteristics.
PMID: 29264933 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Insurance | Liver | Liver Disease | Metformin | Research | Study | Urology & Nephrology